266. HIV Reservoirs and Eradication: Is a Cure on the Horizon?
Saturday, October 10, 2015: 2:00 PM-3:30 PM
Room: 28--ABCDE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • assess the role of innate immunity in efforts to develop a cure for HIV
  • describe the potential of broadly neutralizing antibodies in preventing and eradicating HIV
  • summarize progress in clinical trials aimed at curing HIV

Target Audience: Researchers, Infectious diseases physicians, Infectious diseases pediatricians, HIV specialists, HIV clinicians, Clinicians, Academicians

Tracks: HIV-STD-TB, Adult ID

Moderators:  Rajesh Gandhi, MD, FIDSA, Massachusetts General Hospital and Ragon Institute and Christine Durand, MD, Johns Hopkins University School of Medicine

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits:

ACPE Number:


R. Gandhi, Gilead: Recipient of educational grant , Educational grant
EBSCO: Educational grant recipient , Educational grant
Roche: Educational grant recipient , Educational grant

C. Durand, Gilead Sciences: Scientific Advisor , Research grant

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.